NHS approves new treatment for aggressive cancer that could triple life expectancy - Also known as Ziihera, the antibody treatment targets a protein called HER2, which stimulates tumour growth. It wor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results